Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANOFI CONSUMER HEALTHCARE INDIA LTD.

NSE : SANOFICONRBSE : 544250ISIN CODE : INE0UOS01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE5153.2527.6 (+0.54 %)

PREV CLOSE ( ) 5125.65

OPEN PRICE ( ) 5166.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 236

TODAY'S LOW / HIGH ( )5114.00 5266.20

52 WK LOW / HIGH ( )4360.3 5954

NSE5137.5013 (+0.25 %)

PREV CLOSE( ) 5124.50

OPEN PRICE ( ) 5175.50

BID PRICE (QTY) 5137.50 (6)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 10149

TODAY'S LOW / HIGH( ) 5105.00 5263.50

52 WK LOW / HIGH ( )4211.55 5894.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-05 2023

Management Info

Amit Jain - Chairman Himanshu Bakshi - Managing Director

Registered Office

Address Unit 1104, 11th Floor, Godrej Two,Pirojshanagar, Eastern Express Highway,Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone 022 45288855

Email igrc.schil@sanofi.com

Website www.sanofi.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

13Jun Sanofi Consumer Healthcare India infor
Sanofi Consumer Healthcare India has informed that the exchange has rece..

05May Updates on Open Offer
Citigroup Global Markets India Pvt Ltd ("Manager to the Offer") has subm..

02May Updates on Open Offer
Citigroup Global Markets India Pvt Ltd ("Manager to the Offer") has subm..

30Apr Updates on Open Offer
Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has su..

24Apr Updates on Open Offer
Citigroup Global Markets India Pvt. Ltd. ("Manager to the Offer") has su..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 24
Net Profit	500	1810
Gross Profit	668	2468
Operating Profit	692	2836
Net Sales	1726	7245

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

SMS Lifesciences (BSE) 1299.15 (13.58%)	M.Cap ( in Cr)392.77
RPG Life Sciences (BSE) 2645.50 (3.46%)	M.Cap ( in Cr)4375.40
Ajanta Pharma (BSE) 2786.30 (3.18%)	M.Cap ( in Cr)34804.26
Gland Pharma (BSE) 1970.75 (3.94%)	M.Cap ( in Cr)32469.37
NGL Fine-Chem (BSE) 1442.05 (5.00%)	M.Cap ( in Cr)890.90

Shareholding Pattern

	PROMOTERS	60.4%
	MUTUAL FUNDS/UTI	15.09%
	NON-INSTITUTION	10.17%
	FI/BANKS/INSURANCE	9.78%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Bajaj Finserv Healt...	2.17
Sundaram Small Cap ...	1.92
Bajaj Finserv Balan...	1.59
Nippon India Pharma...	1.42
ICICI Pru Smallcap ...	1.33
Aditya Birla SL Sma...	1.28
Aditya Birla SL Pha...	1.27

Risk Disclosures on Derivatives

Smart Quotes

SANOFI CONSUMER HEALTHCARE INDIA LTD.